Blom A, Kolb F, Lumbroso J, Duvillard P, Mamelle G, Morzli K, Ricard M, Spatz A, Petrow P, Margulis A, Avril M-F
Service de Dermatologie, Institut Gustave Roussy, Villejuif.
Ann Dermatol Venereol. 2003 Apr;130(4):417-22.
Merkel cell carcinoma is an aggressive cutaneous neoplasm with a high propensity for nodal metastases. Regional lymph node involvement develops in 45 to 65 p. 100 of patients. We evaluated in Merkel cell carcinoma the use of sentinel lymph node biopsy which allows the identification of occult nodal metastases.
Eleven patients diagnosed with Merkel cell carcinoma without clinical nodal involvement underwent pre-operative lymphoscintigraphy followed by sentinel lymphadenectomy with histologic analysis. Identification of microscopic nodal metastases led to complete lymph node dissection and adjuvant radiation therapy to the lymph node basin.
The sentinel lymph node was successfully identified in 9 patients. Two patients demonstrated metastatic disease in their sentinel lymph nodes. At subsequent complete node dissection, one of two patients had an additional metastatic lymph node. None of the eleven patients experienced recurrent disease at a follow-up varying from 1 to 42 months. One patient with a negative sentinel lymph node experienced lymphoedema.
Our results are consistent with the 14 published studies which totalled 93 patients with Merkel cell carcinoma and identified 29 patients (30 p. 100) with nodal involvement. Metastatic disease was identified only after immunohistochemical analysis in 20 p. 100 of these patients (n=6). Lymph node involvement appears to be a bad prognostic factor with 29.6 p. 100 of disease recurrence, as opposed to 3 p. 100 in patients with an uninvolved sentinel lymph node. Although the prognostic significance of this technique seems interesting, there is no optimal therapeutic approach to sentinel lymph node involvement.
默克尔细胞癌是一种侵袭性皮肤肿瘤,极易发生淋巴结转移。45%至65%的患者会出现区域淋巴结受累。我们评估了前哨淋巴结活检在默克尔细胞癌中的应用,该方法可用于识别隐匿性淋巴结转移。
11例诊断为默克尔细胞癌且无临床淋巴结受累的患者接受了术前淋巴闪烁显像,随后进行前哨淋巴结切除及组织学分析。若显微镜下发现淋巴结转移,则进行完整的淋巴结清扫,并对淋巴结区域进行辅助放疗。
9例患者成功识别出前哨淋巴结。2例患者的前哨淋巴结显示有转移病灶。在随后的完整淋巴结清扫中,2例患者中有1例还有一个额外的转移淋巴结。11例患者在1至42个月的随访中均未出现疾病复发。1例前哨淋巴结阴性的患者出现了淋巴水肿。
我们的结果与已发表的14项研究一致,这些研究共纳入93例默克尔细胞癌患者,其中29例(30%)发现有淋巴结受累。在这些患者中,20%(n = 6)仅在免疫组化分析后才发现转移病灶。淋巴结受累似乎是一个不良预后因素,疾病复发率为29.6%,而前哨淋巴结未受累的患者复发率为3%。尽管这项技术的预后意义似乎很有趣,但对于前哨淋巴结受累尚无最佳治疗方法。